1. Metastatic Pleomorphic Lobular Carcinoma of the Breast to the Urinary Bladder. A Report of 10 Cases and Assessment of TRPS1 in the Differential Diagnosis With Plasmacytoid Urothelial Carcinoma
- Author
-
Zhang, Guan-Nan, Susnik, Barbara, Paulsen, Emma J., Lyons, Lisa L., Delma, Katiana S., Jorda, Merce, Epstein, Jonathan I., and Kryvenko, Oleksandr N.
- Subjects
Diagnosis, Differential -- Methods ,Carcinoma -- Diagnosis -- Care and treatment -- Complications and side effects ,Cancer -- Diagnosis -- Care and treatment -- Complications and side effects ,Urinary tract cancer -- Diagnosis -- Care and treatment -- Complications and side effects ,Biological markers -- Identification and classification - Abstract
* Context.-Metastatic pleomorphic lobular carcinoma (MPLC) to the bladder is rare and has considerable histologic and immunohistochemical overlap with plasmacytoid urothelial carcinoma (PUC). Objective.-To distinguish MPLC from PUC morphologically and immunohistochemically, including a newer marker, TRPS1. Design.-Ten MPLCs to the bladder were reassessed and stained with estrogen, progesterone, and androgen receptors; GATA3; keratin 5/6; HMWK; GCDFP-15; and TRPSl. Sixteen PUCs constituted controls. Results.-We studied 4 transurethral resections of bladder tumors and 6 biopsies from 10 women (median age, 69 years) who had breast cancer on average 15 years prior. Microscopic patterns included single cells and cords of cells (n = 4), nests/sheets of dyscohesive cells (n = 2), or both (n = 4). All tumors had cells with voluminous eosinophilic cytoplasm and eccentric nuclei mimicking PUC, and 7 of 10 tumors had signet ring cells. MPLCs were positive for estrogen (8 of 10), progesterone (3 of 7), and androgen (4 of 10) receptors; GCDFP-15 (7 of 10); GATA3 (9 of 10); HMWK (7 of 8); and TRPS1 (7 of 10). No MPLCs stained for keratin 5/6 (n = 9). Of 16 PUCs, 2 showed faint and 2 demonstrated strong TRSP1 staining; 7 of 16 were negative for p63. Conclusions.-MPLC to bladder often presents in patients with a remote history of breast cancer, exhibiting significant histologic and immunohistochemical overlap with PUC. Based on prior works and the current study, estrogen receptor (particularly SP-1), mammaglobin, and p63 help differentiate MPLC from PUC. Keratin 5/6 may aid in distinguishing a less frequent basal-type PUC because it is typically negative in MPLC. Some PUCs express TRPS1. Caution should be exercised because immunophenotypes of these tumors greatly overlap, and ramifications of misclassification are major. (Arch Pathol Lab Med. 2024;148:1110-1118; doi: 10.5858/arpa.2023-0379-OA), Conventional invasive lobular carcinoma of the breast accounts for 10% to 15% of all breast carcinomas and is the second most common histologic subtype of breast cancer. (1,2) It is [...]
- Published
- 2024
- Full Text
- View/download PDF